InsidersTradesSigma
Follow the 华熙生物 stock price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 华熙生物 has recorded 6 insider filings. Market capitalisation: €17.5bn. The latest transaction was filed on 5 September 2025 (Purchase). Among the most active insiders: 赵毅. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
华熙生物是一家健康和制药领域的公司，在上海证券交易所上市。该公司专注于生物和医药产品的研发。